Back to Fairfax Financial Holdings Ltd. Fairfax Financial Holdings Ltd.

XERSXERS

Showing 3 of 14 quarters

Position history for Fairfax Financial Holdings Ltd.Fairfax Financial Holdings Ltd.'s holdings in Xeris Biopharma Holdings, Inc.

No. Fairfax Financial Holdings exited its XERS position in Q1 2025. Its Q4 2024 13F listed 139,687 shares worth $472,142. Fairfax Financial Holdings already held XERS in its Q4 2021 13F, the earliest on record, and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$485,461

Total Shares Change

-170,937

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$5.58
0
2024-Q4
Decreased
139,687
-18.3%
$472,1420.0%$3.38
0
2024-Q3
Unchanged
170,937
0.0%
$485,4610.0%$2.87
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used